Asia is the latest foreign healthcare market to embrace digital x-ray. Swissray International, which has sold its ddR-MultiSystem to hospitals in the U.S., South America, Western Europe, and Eastern Europe, now counts Kaohsiung Veterans General Hospital
Asia is the latest foreign healthcare market to embrace digital x-ray. Swissray International, which has sold its ddR-MultiSystem to hospitals in the U.S., South America, Western Europe, and Eastern Europe, now counts Kaohsiung Veterans General Hospital in Taiwan as a customer. Sales figures were not disclosed.
Taiwan would like to advance its radiological practices, said Dr. Yang Chien-Fang, Kaoshiung Veterans General Hospitals superintendent, in a written statement. Chien-Fang said he was impressed with the systems ability to store information and display Chinese characters on its console.
This is the first time Swissray has sold x-ray equipmentfilm or digitalto Taiwan. Taiwanese hospitals commonly use film systems, said Dr. Pan Huay-Ben, Kaohsiung Veterans General Hospitals director of radiology.
The U.S. medical community has been slower to accept digital x-ray than overseas medical communities.
For example, fewer than 100 digital radiography systems have been sold worldwide, and only about half of these have gone to sites in the U.S. Both Swissray and GE Medical Systems report rising DR sales, although many are to overseas customers.
In the last four years, Swissray has taken orders for 65 digital units. Of these, 32 will be delivered this spring to sites in Romania (SCAN 2/1/00). GE claims to have sold 23 Revolution XQ/I digital chest systems last year, with about half of these going to U.S. sites (SCAN 10/27/99).
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.